• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GALDERMA Q-MED AB SCULPTRA; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GALDERMA Q-MED AB SCULPTRA; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Granuloma (1876); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
Pharmacovigilance comments: the serious expected events of granuloma skin and mass at implant site were considered possibly related to the treatment.Serious criteria include the need for medical intervention and long standing event suggestive of permanent damage.The patient report contained limited information; time to onset and medical history were not provided.The case meets the criteria for expedited reporting to the regulatory authorities.Engineering narrative: the information in this single case does not suggest involvement of a nonconforming product or quality problem and will not initiate a corrective or preventive action.Manufacturing narrative: lot number was not reported.
 
Event Description
Case reference number (b)(4) is a spontaneous report sent on (b)(6) 2020 by an adult female patient concerning herself.No information about medical history, concomitant medication, history of allergies or previous filler treatments has been provided.On an unknown date, the patient received treatment with sculptra (unknown amount, lot number, injection technique and needle type) at unknown location.Unknown time later, on an unknown date in 2019, the patient had granulomas (granuloma skin) in lower jaw and near nasal labial folds.The patient went to the injector and had examination of lumps (implant site mass), who said that they would go away.But year later, they were still there and very pronounced.On an unknown date, the patient had received unspecified treatment.Outcome at the time of the report: granulomas was not recovered/not resolved.Lumps was not recovered/not resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SCULPTRA
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
GALDERMA Q-MED AB
seminariegatan 21
uppsala, SE-75 228
SW  SE-75228
MDR Report Key10417611
MDR Text Key210178174
Report Number1000118068-2020-00031
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 08/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA08/17/2020
Distributor Facility Aware Date08/06/2020
Event Location Other
Date Report to Manufacturer08/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
-
-